EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program

24.10.24 13:01 Uhr

This article EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program originally appeared on Benzinga.com.Weiter zum vollständigen Artikel bei Benzinga

Quelle: Benzinga

Nachrichten zu Cybin Inc Registered Shs